Global Health Financials
| MEDANTA Stock | 1,193 18.75 1.55% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 14.1 B | 13.5 B |
|
|
Global | Select Account or Indicator |
Please note, the presentation of Global Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Global Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Global Health's management manipulating its earnings.
Global Health Stock Summary
Global Health competes with Viceroy Hotels, Ankit Metal, EIH Associated, Rajnandini Metal, and Lemon Tree. Global Health is entity of India. It is traded as Stock on NSE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE474Q01031 |
| Business Address | E-18, Defence Colony, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.medanta.org |
| Phone | 91 11 4411 4411 |
You should never invest in Global Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Global Stock, because this is throwing your money away. Analyzing the key information contained in Global Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Global Health Key Financial Ratios
Global Health's financial ratios allow both analysts and investors to convert raw data from Global Health's financial statements into concise, actionable information that can be used to evaluate the performance of Global Health over time and compare it to other companies across industries.| Revenue | 32.75 B | ||||
| Gross Profit | 18.37 B | ||||
| EBITDA | 8.72 B | ||||
| Net Income | 4.78 B | ||||
| Total Asset | 43.04 B |
Global Health Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 26.9B | 31.5B | 41.2B | 43.0B | 49.5B | 33.6B | |
| Other Current Liab | 1.4B | 1.8B | 983.5M | 2.6B | 3.0B | 1.9B | |
| Net Debt | 8.6B | 9.9B | 3.5B | 3.8B | 3.4B | 5.1B | |
| Retained Earnings | 7.7B | 9.5B | 12.8B | 17.6B | 20.3B | 10.7B | |
| Accounts Payable | 1.3B | 1.3B | 1.9B | 1.9B | 2.1B | 1.4B | |
| Cash | 694.7M | 1.2B | 7.7B | 4.2B | 4.9B | 2.6B | |
| Net Receivables | 1.7B | 2.2B | 1.9B | 2.4B | 2.7B | 2.1B | |
| Inventory | 397.6M | 533.9M | 603.7M | 668.5M | 768.8M | 483.9M | |
| Other Current Assets | 63.1M | 2.5B | 141.3M | 496.4M | 570.8M | 551.2M | |
| Total Liab | 13.1B | 15.3B | 16.9B | 14.0B | 16.1B | 14.4B | |
| Total Current Assets | 5.0B | 8.1B | 15.8B | 15.1B | 17.4B | 9.2B | |
| Short Term Debt | 1.0B | 1.1B | 1.4B | 1.7B | 2.0B | 1.1B | |
| Intangible Assets | 72.5M | 62.7M | 51.7M | 55.4M | 63.7M | 56.0M | |
| Common Stock | 820.9M | 506.5M | 536.4M | 537.0M | 483.3M | 479.5M | |
| Long Term Debt | 5.8B | 7.7B | 7.4B | 2.8B | 2.6B | 4.8B | |
| Net Invested Capital | 20.3B | 24.5B | 32.7B | 33.2B | 38.2B | 28.7B | |
| Short Long Term Debt | 669.0M | 702.3M | 1.1B | 1.4B | 1.6B | 867.9M | |
| Capital Stock | 820.9M | 506.5M | 536.4M | 537.0M | 483.3M | 515.1M | |
| Net Working Capital | 974.7M | 3.9B | 10.1B | 8.9B | 10.2B | 5.5B |
Global Health Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Revenue | 14.3B | 21.6B | 26.9B | 32.8B | 37.7B | 21.8B | |
| Gross Profit | 10.8B | 16.1B | 20.7B | 17.2B | 19.7B | 13.0B | |
| Operating Income | 927.0M | 3.4B | 5.3B | 11.7B | 13.5B | 14.1B | |
| Ebit | 1.1B | 3.5B | 5.3B | 7.0B | 8.0B | 8.4B | |
| Research Development | 270K | 590K | 340K | 420K | 378K | 359.1K | |
| Ebitda | 2.3B | 4.8B | 6.8B | 8.7B | 10.0B | 10.5B | |
| Cost Of Revenue | 3.5B | 5.4B | 6.3B | 15.6B | 17.9B | 18.8B | |
| Income Before Tax | 324.6M | 2.8B | 4.5B | 6.3B | 7.2B | 7.6B | |
| Net Income | 288.1M | 2.0B | 3.3B | 4.8B | 5.5B | 5.8B | |
| Income Tax Expense | 36.6M | 843.6M | 1.2B | 1.5B | 1.7B | 1.8B | |
| Interest Expense | 671.0M | 789.6M | 779.2M | 725.4M | 834.2M | 768.4M | |
| Tax Provision | 36.6M | 843.6M | 1.2B | 1.5B | 1.7B | 1.8B | |
| Net Interest Income | (548.8M) | (696.0M) | (779.2M) | (241.0M) | (277.2M) | (291.0M) | |
| Interest Income | 177.6M | 167.2M | 355.4M | 596.8M | 686.3M | 720.6M |
Global Health Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Global Health Limited. It measures of how well Global is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Global Health brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Global had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Global Health has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Other Non Cash Items | 325.4M | 534.7M | (575.1M) | 141.4M | 127.3M | 120.9M | |
| Capital Expenditures | 1.5B | 2.7B | 2.4B | 2.8B | 3.2B | 2.2B | |
| Net Income | 324.6M | 2.8B | 4.5B | 4.8B | 5.5B | 5.8B | |
| End Period Cash Flow | 694.7M | 1.2B | 7.7B | 4.2B | 4.9B | 2.6B | |
| Change To Inventory | (12.4M) | (136.3M) | (69.8M) | (64.8M) | (58.3M) | (61.2M) | |
| Change In Cash | (781.1M) | 499.7M | 6.5B | (3.4B) | (3.9B) | (3.7B) | |
| Free Cash Flow | 960.3M | 367.9M | 4.1B | 3.3B | 3.8B | 4.0B | |
| Depreciation | 1.2B | 1.3B | 1.5B | 1.7B | 2.0B | 1.5B | |
| Investments | (2.4B) | (4.2B) | (3.4B) | (4.4B) | (4.0B) | (4.2B) |
Global Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Global Health's current stock value. Our valuation model uses many indicators to compare Global Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Global Health competition to find correlations between indicators driving Global Health's intrinsic value. More Info.Global Health Limited is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Global Health Limited is roughly 1.93 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Global Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Global Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Global Health Limited Systematic Risk
Global Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Global Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Global Health Limited correlated with the market. If Beta is less than 0 Global Health generally moves in the opposite direction as compared to the market. If Global Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Global Health Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Global Health is generally in the same direction as the market. If Beta > 1 Global Health moves generally in the same direction as, but more than the movement of the benchmark.
Global Health Limited Total Assets Over Time
Global Health Thematic Clasifications
Global Health Limited is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
| Health Management | View |
Global Health February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Global Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Global Health Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Global Health Limited based on widely used predictive technical indicators. In general, we focus on analyzing Global Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Global Health's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.71 | |||
| Information Ratio | 0.065 | |||
| Maximum Drawdown | 13.94 | |||
| Value At Risk | (2.49) | |||
| Potential Upside | 3.54 |
Complementary Tools for Global Stock analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |